Merck extends 2 million euros support to India for coronavirus relief

Science and technology firm Merck on Tuesday announced a support of 2 million euros (Rs 17.85 crore) for India to help the country fight against Covid-19

merck
Photo: Reuters
Press Trust of India New Delhi
2 min read Last Updated : Jun 01 2021 | 6:10 PM IST

Science and technology firm Merck on Tuesday announced a support of 2 million euros (Rs 17.85 crore) for India to help the country fight against COVID-19.

The aid is being utilised for procuring 250 oxygen concentrators, 100 ventilators, and setting up of oxygen generation plants in four hospitals, Merck said in a statement.

Merck India is working with state governments, government departments and non-profit service organisations managing COVID care for putting this aid to use of people who may be needing it the most, it added.

A part of this aid will also be utilised to procure medicines for emergency care of employees and their families, Merck said.

"We are happy to extend this care and are confident that our aid will be supplementing the government's efforts in addressing the need of the patients," Sunil Punjabi, Country Speaker and Head of Research Solutions, Life Science, Merck said.

As part of its regular CSR activities, Merck had earlier donated over 1.6 lakh face masks, disinfectants and thermal temperature scanners to the frontline and health departments as well as dry rations to migrant workers' families around its manufacturing sites, Merck said.

The company has also contributed to the state relief funds in Karnataka and Maharashtra, and to the PM CARES fund, towards COVID relief, it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusMerckCoronavirus Vaccine

First Published: Jun 01 2021 | 6:04 PM IST

Next Story